Céline Sarr, Ph.D.

Principal Consultant


  • Joined Pharmetheus in 2016, actively working in client projects, leading the Client Operations Forum, and serving as Project Portfolio Team Leader and Pharmacometrics Platform Business Development Lead
  • Expertise includes pharmacometrics, submission, pediatric investigation plans, and MIDD support in therapeutic areas such as oncology and metabolism disorders
  • Previously worked as Senior Consultant at SGS-Exprimo, Belgium, where she delivered modeling results to support submissions and internal decisions, as Senior Expert Modeler at Novartis, Switzerland, Cluster Leader at Novartis, USA, and Modeler at Novartis, Switzerland
  • Pharm.D. (2004) from University Paris XII, France, and Ph.D. in Pharmaceutical Biosciences (2006) from University Lyon Claude Bernard, France
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorderA framework for prediction of progression free survival based on modelling of sub-endpointsApplication of tumor size modelling and simulations to support the dose selection of BI 907828 for a Phase II studyPopulation PK analysis of Pegaspargase in Japanese and non-Japanese patients with acute lymphoblastic leukemiaHow to Successfully Generate an Alternative Approach to a Thorough QT Study: GLPG1972 as an ExampleExposure–Safety Analyses of Nintedanib in Patients with Chronic Fibrosing Interstitial Lung DiseaseThe Standard Output: A Tool-Agnostic Modeling Storage FormatPopulation PK and PASI Exposure-Response Modelling for Certolizumab Pegol in Patients with Chronic Plaque PsoriasisOpen Innovation: Towards Sharing of Data, Models and Workflows